Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Post by farmerjaneon Oct 12, 2013 2:11pm
293 Views
Post# 21813187

Might be good

Might be goodLooks to me like they are winding down, and the question is why did Meryl and Michael leave ? I don't think it is because the ship is sinking, I think it is probably  for personal gain. They now become outsiders  knowing what Amorfix has. May-be allows them to add more to their  war chess with PP's or some other method.  Michael is tied to the Hip with Hans Black, when Hans came aboard Nov 28,2006 Michael was on board by Jan 10, 2007. They might even sit on other boards together. Michael  was the only board member that sat on all 5 subcomittees including my favorite the compensation comittee.  Over the last few months members have been suggesting we have a licensing deal coming, i have been saying for 2 years now you are not going to see this. The real objective of the company, though not stated is to prove up the science as much as they can and let it go...with the insiders / and recent insiders making a bucket full. Lets see if I'm right ?
Bullboard Posts